The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Drug repurposing for antimicrobial discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Drug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Ariey, F., Witkowski, B., Amaratunga, C., Beghain, J., Langlois, A.-C., Khim, N., Kim, S., Duru, V., Bouchier, C., Ma, L., et al. (2014) · Nature · doi:10.1038/nature12876 · Cited by 2,090
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
Robert-Gangneux, F., & Dardé, M.-L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05013-11 · Cited by 1,815
Outer membrane permeability and antibiotic resistance
Delcour, A. H. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.005 · Cited by 1,762
The ChEMBL bioactivity database: an update
Bento, A. P., Gaulton, A., Hersey, A., Bellis, L. J., Chambers, J., Davies, M., Krüger, F. A., Light, Y., Mak, L., McGlinchey, S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1031 · Cited by 1,492
The SIDER database of drugs and side effects
Kuhn, M., Letunic, I., Jensen, L. J., & Bork, P. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1075 · Cited by 1,451
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Waring, M. J., Arrowsmith, J., Leach, A. R., Leeson, P. D., Mandrell, S., Owen, R. M., Pairaudeau, G., Pennie, W. D., Pickett, S. D., Wang, J., et al. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4609 · Cited by 1,450
A SEX-CHROMOSOME ANOMALY IN A CASE OF GONADAL DYSGENESIS (TURNER'S SYNDROME)
FORD, C. (1959) · The Lancet · doi:10.1016/s0140-6736(59)91893-8 · Cited by 1,354
Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth
Tang, H., Hammack, C., Ogden, S. C., Wen, Z., Qian, X., Li, Y., Yao, B., Shin, J., Zhang, F., Lee, E. M., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.02.016 · Cited by 1,292
Target identification and mechanism of action in chemical biology and drug discovery
Schenone, M., Dančík, V., Wagner, B. K., & Clemons, P. A. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1199 · Cited by 1,096
The Drug Repurposing Hub: a next-generation drug library and information resource
Corsello, S. M., Bittker, J. A., Liu, Z., Gould, J., McCarren, P., Hirschman, J. E., Johnston, S. E., Vrcic, A., Wong, B., Khan, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4306 · Cited by 1,015
Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics
Schulz, M., Iwersen-Bergmann, S., Andresen, H., & Schmoldt, A. (2012) · Critical Care · doi:10.1186/cc11441 · Cited by 1,009
Chong, C. R., & Sullivan, D. J. (2007) · Nature · doi:10.1038/448645a · Cited by 983
The Connectivity Map: A new tool for biomedical research
Lamb, J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2044 · Cited by 945
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Lehár, J., Krueger, A. S., Avery, W., Heilbut, A. M., Johansen, L. M., Price, E. R., Rickles, R. J., Short III, G. F., Staunton, J. E., Jin, X., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1549 · Cited by 938
Snitkin, E. S., Zelazny, A. M., Thomas, P. J., Stock, F., Program, N. C. S., Henderson, D. K., Palmore, T. N., & Segre, J. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004129 · Cited by 863
Global mapping of pharmacological space
Paolini, G. V., Shapland, R. H. B., van Hoorn, W. P., Mason, J. S., & Hopkins, A. L. (2006) · Nature Biotechnology · doi:10.1038/nbt1228 · Cited by 811
Yarchoan, R., Weinhold, K., Lyerly, H. K., Gelmann, E., Blum, R., Shearer, G., Mitsuya, H., Collins, J., Myers, C., Klecker, R., et al. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92808-4 · Cited by 802
Statistical practice in high-throughput screening data analysis
Malo, N., Hanley, J. A., Cerquozzi, S., Pelletier, J., & Nadon, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1186 · Cited by 721
In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
Ekins, S., Mestres, J., & Testa, B. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707305 · Cited by 703
Update on the antibiotic resistance crisis
Rossolini, G. M., Arena, F., Pecile, P., & Pollini, S. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.09.006 · Cited by 695
Dyall, J., Coleman, C. M., Hart, B. J., Venkataraman, T., Holbrook, M. R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Jahrling, P. B., Laidlaw, M., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03036-14 · Cited by 660
Multidrug Resistance: An Emerging Crisis
Tanwar, J., Das, S., Fatima, Z., & Hameed, S. (2014) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2014/541340 · Cited by 657
Xu, M., Lee, E. M., Wen, Z., Cheng, Y., Huang, W.-K., Qian, X., TCW, J., Kouznetsova, J., Ogden, S. C., Hammack, C., et al. (2016) · Nature Medicine · doi:10.1038/nm.4184 · Cited by 641
Combination approaches to combat multidrug-resistant bacteria
Worthington, R. J., & Melander, C. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.12.006 · Cited by 625
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
Ejim, L., Farha, M. A., Falconer, S. B., Wildenhain, J., Coombes, B. K., Tyers, M., Brown, E. D., & Wright, G. D. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.559 · Cited by 525
Self-citationExploring the Mode-of-Action of Bioactive Compounds by Chemical-Genetic Profiling in Yeast
Parsons, A. B., Lopez, A., Givoni, I. E., Williams, D. E., Gray, C. A., Porter, J., Chua, G., Sopko, R., Brost, R. L., Ho, C.-H., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.040 · Cited by 515
Auranofin: Repurposing an Old Drug for a Golden New Age
Roder, C., & Thomson, M. J. (2015) · Drugs in R&D · doi:10.1007/s40268-015-0083-y · Cited by 497
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
Barrows, N. J., Campos, R. K., Powell, S. T., Prasanth, K. R., Schott-Lerner, G., Soto-Acosta, R., Galarza-Muñoz, G., McGrath, E. L., Urrabaz-Garza, R., Gao, J., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.07.004 · Cited by 497
Lack of development of new antimicrobial drugs: a potential serious threat to public health
Norrby, S. R., Nord, C. E., & Finch, R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)01283-1 · Cited by 491
Evaluating treatment protocols to prevent antibiotic resistance
Bonhoeffer, S., Lipsitch, M., & Levin, B. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12106 · Cited by 487
Shifting from the single to the multitarget paradigm in drug discovery
Medina-Franco, J. L., Giulianotti, M. A., Welmaker, G. S., & Houghten, R. A. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.01.008 · Cited by 483
Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives
Gygli, S. M., Borrell, S., Trauner, A., & Gagneux, S. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux011 · Cited by 457
Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics.
Schulz, M., & Schmoldt, A. (2003) · PubMed · Cited by 439
Drug combination therapy increases successful drug repositioning
Sun, W., Sanderson, P. E., & Zheng, W. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.05.015 · Cited by 436
Phenotypic screens as a renewed approach for drug discovery
Zheng, W., Thorne, N., & McKew, J. C. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.001 · Cited by 423
Huang, R., Southall, N., Wang, Y., Yasgar, A., Shinn, P., Jadhav, A., Nguyen, D.-T., & Austin, C. P. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001862 · Cited by 401
Ten common questions (and their answers) about off-label drug use
Wittich, C. M., Burkle, C. M., & Lanier, W. L. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.04.017 · Cited by 368
Drug repurposing from an academic perspective
Oprea, T. I., Bauman, J. E., Bologa, C. G., Buranda, T., Chigaev, A., Edwards, B. S., Jarvik, J. W., Gresham, H. D., Haynes, M. K., Hjelle, B., et al. (2011) · Drug Discovery Today: Therapeutic Strategies · doi:10.1016/j.ddstr.2011.10.002 · Cited by 364
The biology and toxicology of molluscicides, bayluscide
Andrews, P., Thyssen, J., & Lorke, D. (1982) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(82)90064-x · Cited by 347
Stokes, J. M., MacNair, C. R., Ilyas, B., French, S., Côté, J.-P., Bouwman, C., Farha, M. A., Sieron, A. O., Whitfield, C., Coombes, B. K., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.28 · Cited by 340
Self-citationAntifungal Chemical Compounds Identified Using a C. elegans Pathogenicity Assay
Breger, J., Fuchs, B. B., Aperis, G., Moy, T. I., Ausubel, F. M., & Mylonakis, E. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030018 · Cited by 332
Drug repositioning and repurposing: terminology and definitions in literature
Langedijk, J., Mantel-Teeuwisse, A. K., Slijkerman, D. S., & Schutjens, M.-H. D. B. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.05.001 · Cited by 323
Kinnings, S. L., Liu, N., Buchmeier, N., Tonge, P. J., Xie, L., & Bourne, P. E. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000423 · Cited by 319
A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target
Debnath, A., Parsonage, D., Andrade, R. M., He, C., Cobo, E. R., Hirata, K., Chen, S., García-Rivera, G., Orozco, E., Martínez, M. B., et al. (2012) · Nature Medicine · doi:10.1038/nm.2758 · Cited by 306
A standard database for drug repositioning
Brown, A. S., & Patel, C. J. (2017) · Scientific Data · doi:10.1038/sdata.2017.29 · Cited by 305
Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa
Carroll, M. W., Matthews, D. A., Hiscox, J. A., Elmore, M. J., Pollakis, G., Rambaut, A., Hewson, R., García-Dorival, I., Bore, J. A., Koundouno, R., et al. (2015) · Nature · doi:10.1038/nature14594 · Cited by 302
A Case of Severe Ebola Virus Infection Complicated by Gram-Negative Septicemia
Kreuels, B., Wichmann, D., Emmerich, P., Schmidt-Chanasit, J., de Heer, G., Kluge, S., Sow, A., Renné, T., Günther, S., Lohse, A. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1411677 · Cited by 302
Meyerhoff, A. (1999) · Clinical Infectious Diseases · doi:10.1086/515085 · Cited by 295
A clinical drug library screen identifies astemizole as an antimalarial agent
Chong, C. R., Chen, X., Shi, L., Liu, J. O., & Sullivan, D. J. (2006) · Nature Chemical Biology · doi:10.1038/nchembio806 · Cited by 289
Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics
MacNair, C. R., Stokes, J. M., Carfrae, L. A., Fiebig-Comyn, A. A., Coombes, B. K., Mulvey, M. R., & Brown, E. D. (2018) · Nature Communications · doi:10.1038/s41467-018-02875-z · Cited by 287
Self-citationWang, Y., Suzek, T., Zhang, J., Wang, J., He, S., Cheng, T., Shoemaker, B. A., Gindulyte, A., & Bryant, S. H. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt978 · Cited by 284
Hernandez, J. J., Pryszlak, M., Smith, L., Yanchus, C., Kurji, N., Shahani, V. M., & Molinski, S. V. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00273 · Cited by 281
Repurposing drugs in oncology (ReDO)—Cimetidine as an anti-cancer agent
Pantziarka, P. (2014) · ecancermedicalscience · doi:10.3332/ecancer.2014.485 · Cited by 280
Antimicrobial interactions: mechanisms and implications for drug discovery and resistance evolution
Bollenbach, T. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.05.008 · Cited by 261
Katlama, C., De Wit, S., O'Doherty, E., Van Glabeke, M., Clumeck, N., & European Network for Treatment of AIDS (ENTA) Toxoplasmosis Study Group (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.268 · Cited by 253
Drug repositioning for personalized medicine
Li, Y. Y., & Jones, S. J. (2012) · Genome Medicine · doi:10.1186/gm326 · Cited by 248
Evaluation of Ebola Virus Inhibitors for Drug Repurposing
Madrid, P. B., Panchal, R. G., Warren, T. K., Shurtleff, A. C., Endsley, A. N., Green, C. E., Kolokoltsov, A., Davey, R., Manger, I. D., Gilfillan, L., et al. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00030 · Cited by 247
Johansen, L. M., DeWald, L. E., Shoemaker, C. J., Hoffstrom, B. G., Lear-Rooney, C. M., Stossel, A., Nelson, E., Delos, S. E., Simmons, J. A., Grenier, J. M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5597 · Cited by 236
On the Integration of In Silico Drug Design Methods for Drug Repurposing
March-Vila, E., Pinzi, L., Sturm, N., Tinivella, A., Engkvist, O., Chen, H., & Rastelli, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00298 · Cited by 235
Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects
Jurgeit, A., McDowell, R., Moese, S., Meldrum, E., Schwendener, R., & Greber, U. F. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002976 · Cited by 231
Lu, W., Lin, C., Roberts, M. J., Waud, W. R., Piazza, G. A., & Li, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029290 · Cited by 230
Tan, K. R., Magill, A. J., Parise, M. E., & Arguin, P. M. (2011) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2011.10-0285 · Cited by 227
Kouznetsova, J., Sun, W., Martínez-Romero, C., Tawa, G., Shinn, P., Chen, C. Z., Schimmer, A., Sanderson, P., McKew, J. C., Zheng, W., et al. (2014) · Emerging Microbes & Infections · doi:10.1038/emi.2014.88 · Cited by 227
PROMISCUOUS: a database for network-based drug-repositioning
von Eichborn, J., Murgueitio, M. S., Dunkel, M., Koerner, S., Bourne, P. E., & Preissner, R. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1037 · Cited by 225
Inhibition of WTA Synthesis Blocks the Cooperative Action of PBPs and Sensitizes MRSA to β-Lactams
Farha, M. A., Leung, A., Sewell, E. W., D’Elia, M. A., Allison, S. E., Ejim, L., Pereira, P. M., Pinho, M. G., Wright, G. D., & Brown, E. D. (2013) · ACS Chemical Biology · doi:10.1021/cb300413m · Cited by 216
Self-citationRevisiting the host as a growth medium
Brown, S. A., Palmer, K. L., & Whiteley, M. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1955 · Cited by 208
Zhai, B., Wu, C., Wang, L., Sachs, M. S., & Lin, X. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00212-12 · Cited by 205
Imperi, F., Massai, F., Ramachandran Pillai, C., Longo, F., Zennaro, E., Rampioni, G., Visca, P., & Leoni, L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01952-12 · Cited by 197
Cross‐species discovery of syncretic drug combinations that potentiate the antifungal fluconazole
Spitzer, M., Griffiths, E., Blakely, K. M., Wildenhain, J., Ejim, L., Rossi, L., De Pascale, G., Curak, J., Brown, E., Tyers, M., et al. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.31 · Cited by 183
Self-citationRhein, J., Morawski, B. M., Hullsiek, K. H., Nabeta, H. W., Kiggundu, R., Tugume, L., Musubire, A., Akampurira, A., Smith, K. D., Alhadab, A., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00074-8 · Cited by 183
Identifying mechanism-of-action targets for drugs and probes
Gregori-Puigjané, E., Setola, V., Hert, J., Crews, B. A., Irwin, J. J., Lounkine, E., Marnett, L., Roth, B. L., & Shoichet, B. K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204524109 · Cited by 182
(2016) · ecancermedicalscience · doi:10.3332/ecancer.2014.442 · Cited by 173
SEVERELY DISTURBED ADOLESCENTS
(1970) · The Lancet · doi:10.1016/s0140-6736(70)90823-8 · Cited by 171
Drug resistance in eukaryotic microorganisms
Fairlamb, A. H., Gow, N. A. R., Matthews, K. R., & Waters, A. P. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.92 · Cited by 170
Li, R., Hu, Z., Sun, S., Chen, Z. G., Owonikoko, T. K., Sica, G., Ramalingam, S. S., Curran, W. J., Khuri, F. R., & Deng, X. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0095 · Cited by 167
Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity
Imperi, F., Massai, F., Facchini, M., Frangipani, E., Visaggio, D., Leoni, L., Bragonzi, A., & Visca, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222706110 · Cited by 166
A Reprofiled Drug, Auranofin, Is Effective against Metronidazole-Resistant Giardia lamblia
Tejman-Yarden, N., Miyamoto, Y., Leitsch, D., Santini, J., Debnath, A., Gut, J., McKerrow, J. H., Reed, S. L., & Eckmann, L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01675-12 · Cited by 162
Optimal Drug Synergy in Antimicrobial Treatments
Torella, J. P., Chait, R., & Kishony, R. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000796 · Cited by 162
Discovery and preclinical development of new antibiotics
Hughes, D., & Karlén, A. (2014) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2014.896437 · Cited by 157
He, S., Lin, B., Chu, V., Hu, Z., Hu, X., Xiao, J., Wang, A. Q., Schweitzer, C. J., Li, Q., Imamura, M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010286 · Cited by 150
Discovery of Antivirulence Agents against Methicillin-Resistant Staphylococcus aureus
Khodaverdian, V. Y., Pesho, M. M., Truitt, B. J., Bollinger, L. B., Patel, P., Nithianantham, S., Yu, G.-P., Delaney, E., Jankowsky, E., & Shoham, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00269-13 · Cited by 150
TDR Targets: a chemogenomics resource for neglected diseases
Magariños, M. P., Carmona, S. J., Crowther, G. J., Ralph, S. A., Roos, D. S., Shanmugam, D., Voorhis, W. C. V., & Agüero, F. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1053 · Cited by 147
Liver-stage malaria parasites vulnerable to diverse chemical scaffolds
Derbyshire, E. R., Prudêncio, M., Mota, M. M., & Clardy, J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118370109 · Cited by 144
Bessoff, K., Sateriale, A., Lee, K. K., & Huston, C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02460-12 · Cited by 128
Searching for New Antimalarial Therapeutics amongst Known Drugs
Weisman, J. L., Liou, A. P., Shelat, A. A., Cohen, F. E., Guy, R. K., & DeRisi, J. L. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2006.00391.x · Cited by 127
Zika Virus: Rapid Spread in the Western Hemisphere
Chen, L. H., & Hamer, D. H. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0150 · Cited by 122
Siles, S. A., Srinivasan, A., Pierce, C. G., Lopez-Ribot, J. L., & Ramasubramanian, A. K. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00680-13 · Cited by 120
Computational and Practical Aspects of Drug Repositioning
Oprea, T. I., & Overington, J. P. (2015) · Assay and Drug Development Technologies · doi:10.1089/adt.2015.29011.tiodrrr · Cited by 119
Mullard, A. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4239 · Cited by 116
Antifungal activity in Saccharomyces cerevisiae is modulated by calcium signalling
Edlind, T., Smith, L., Henry, K., Katiyar, S., & Nickels, J. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03165.x · Cited by 114
Drug Screen Targeted at Plasmodium Liver Stages Identifies a Potent Multistage Antimalarial Drug
da Cruz, F. P., Martin, C., Buchholz, K., Lafuente-Monasterio, M. J., Rodrigues, T., Sönnichsen, B., Moreira, R., Gamo, F., Marti, M., Mota, M. M., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis184 · Cited by 114
Antifungal Activity of Tamoxifen: In Vitro and In Vivo Activities and Mechanistic Characterization
Dolan, K., Montgomery, S., Buchheit, B., DiDone, L., Wellington, M., & Krysan, D. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01564-08 · Cited by 112
Shameer, K., Glicksberg, B. S., Hodos, R. A., Johnson, K. W., Badgeley, M. A., Readhead, B., Tomlinson, M., O’Connor, T., Miotto, R., Kidd, B. A., et al. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw136 · Cited by 111
Fungal Infections Associated with Contaminated Methylprednisolone Injections
Kauffman, C. A., Pappas, P. G., & Patterson, T. F. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1212617 · Cited by 109
Engel, J. C., Ang, K. K. H., Chen, S., Arkin, M. R., McKerrow, J. H., & Doyle, P. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01777-09 · Cited by 107
Farha, M. A., Czarny, T. L., Myers, C. L., Worrall, L. J., French, S., Conrady, D. G., Wang, Y., Oldfield, E., Strynadka, N. C. J., & Brown, E. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511751112 · Cited by 104
Self-citationSuperDRUG2: a one stop resource for approved/marketed drugs
Siramshetty, V. B., Eckert, O. A., Gohlke, B.-O., Goede, A., Chen, Q., Devarakonda, P., Preißner, S., & Preißner, R. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1088 · Cited by 100
FDA's Expedited Approval Mechanisms for New Drug Products
Kepplinger, E. E. (2015) · Biotechnology Law Report · doi:10.1089/blr.2015.9999 · Cited by 99
Synergistic drug combination effectively blocks Ebola virus infection
Sun, W., He, S., Martínez‐Romero, C., Kouznetsova, J., Tawa, G. J., Xu, M., Shinn, P., Fisher, E. G., Long, Y., Motabar, O., et al. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.017 · Cited by 99
Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections
Younis, W., Thangamani, S., & Seleem, M. N. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150506154434 · Cited by 99
Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect
Zhai, B., Zhou, H., Yang, L., Zhang, J., Jung, K., Giam, C., Xiang, X., & Lin, X. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq046 · Cited by 98
Czyż, D. M., Potluri, L., Jain‐Gupta, N., Riley, S. P., Martinez, J. J., Steck, T. L., Crosson, S., Shuman, H. A., & Gabay, J. E. (2014) · mBio · doi:10.1128/mbio.01534-14 · Cited by 98
Discovery of a small molecule that inhibits bacterial ribosome biogenesis
Stokes, J. M., Davis, J. H., Mangat, C. S., Williamson, J. R., & Brown, E. D. (2014) · eLife · doi:10.7554/elife.03574 · Cited by 97
Self-citationRajamuthiah, R., Fuchs, B. B., Jayamani, E., Kim, Y., Larkins‐Ford, J., Conery, A. L., Ausubel, F. M., & Mylonakis, E. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089189 · Cited by 96
Butts, A., DiDone, L., Koselny, K., Baxter, B. K., Chabrier-Rosello, Y., Wellington, M., & Krysan, D. J. (2013) · Eukaryotic Cell · doi:10.1128/ec.00314-12 · Cited by 95
Synergy Testing of FDA-Approved Drugs Identifies Potent Drug Combinations against Trypanosoma cruzi
Planer, J. D., Hulverson, M. A., Arif, J. A., Ranade, R. M., Don, R., & C, F. S. B. A. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002977 · Cited by 94
Lass-Florl, C. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.6.775 · Cited by 92
Moroney, J. W., Fu, S., Moulder, S. L., Falchook, G. S., Helgason, T., Levenback, C., Hong, D. S., Naing, A., Wheler, J. J., & Kurzrock, R. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1158 · Cited by 92
Confronting the challenges of discovery of novel antibacterial agents
Singh, S. B. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.06.053 · Cited by 92
Delattin, N., Brucker, K. D., Vandamme, K., Meert, E. M. K., Marchand, A., Chaltin, P., Cammue, B. P. A., & Thevissen, K. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt449 · Cited by 89
Khanim, F. L., Merrick, B., Giles, H. V., Jankute, M., JACKSON, J. B., Giles, L., Birtwistle, J., Bunce, C. M., & Drayson, M. T. (2011) · Blood Cancer Journal · doi:10.1038/bcj.2011.38 · Cited by 86
Drug repurposing programmes get lift off
Mullard, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3776 · Cited by 86
Sun, W., Weingarten, R. A., Xu, M., Southall, N. T., Dai, S., Shinn, P., Sanderson, P. E. J., Williamson, P. R., Frank, K. M., & Zheng, W. (2016) · Emerging Microbes & Infections · doi:10.1038/emi.2016.123 · Cited by 82
Chockalingam, K., Simeon, R. L., Rice, C. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915117107 · Cited by 81
Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique
Ye, Y., Zhang, X., Zhang, T., Wang, H., & Wu, B. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2014.954585 · Cited by 78
Gene Expression Signature-Based Screening Identifies New Broadly Effective Influenza A Antivirals
Josset, L., Textoris, J., Loriod, B., Ferraris, O., Moulés, V., Lina, B., Nguyen, C., Diaz, J., & Rosa‐Calatrava, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013169 · Cited by 77
Jacobs, A. C., DiDone, L., Jobson, J., Sofia, M. K., Krysan, D. J., & Dunman, P. M. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01640-12 · Cited by 76
Carlson-Banning, K. M., Chou, A., Liu, Z., Hamill, R. J., Song, Y., & Zechiedrich, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069646 · Cited by 73
Smorenburg, C. H., Seynaeve, C., Bontenbal, M., Planting, A. S. T., SINDERMANN, H., & Verweij, J. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200011000-00006 · Cited by 73
Iwata, H., Sawada, R., Mizutani, S., & Yamanishi, Y. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500670q · Cited by 70
Mook, R. A., Wang, J., Ren, X.-R., Chen, M., Spasojević, I., Barak, L. S., Lyerly, H. K., & Chen, W. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.07.001 · Cited by 68
A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases
Berenstein, A. J., Magariños, M. P., Chernomoretz, A., & Agüero, F. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004300 · Cited by 67
New drug target in protozoan parasites: the role of thioredoxin reductase
Andrade, R. M., & Reed, S. L. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00975 · Cited by 66
Hepatitis C can be cured globally, but at what cost?
Hill, A., & Cooke, G. (2014) · Science · doi:10.1126/science.1257737 · Cited by 65
Deng, L., Sundriyal, S., Rubio, V., Shi, Z.-Z., & Song, Y. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9012592 · Cited by 65
Astolfi, A., Felicetti, T., Iraci, N., Manfroni, G., Massari, S., Pietrella, D., Tabarrini, O., Kaatz, G. W., Barreca, M. L., Sabatini, S., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01439 · Cited by 64
Forsberg, M., Lehtonen, M., Heikkinen, M., Savolainen, J., Järvinen, T., & Männistö, P. T. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042846 · Cited by 63
Antifungal Activity againstCandidaSpecies of the Selective Serotonin‐Reuptake Inhibitor, Sertraline
Lass‐Flörl, C., Dierich, M. P., Fuchs, D., Semenitz, E. I., & Ledochowski, M. (2001) · Clinical Infectious Diseases · doi:10.1086/324589 · Cited by 61
Unconventional screening approaches for antibiotic discovery
Farha, M. A., & Brown, E. D. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12803 · Cited by 60
Self-citationIdentification of new drug candidates against Borrelia burgdorferi using high-throughput screening
Pothineni, V. R., Wagh, D. A., Babar, M. M., Inayathullah, M., Solow-Cordero, D. E., Kim, K., Samineni, A. V., Parekh, M. B., Tayebi, L., & Rajadas, J. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s101486 · Cited by 60
New role for FDA-approved drugs in combating antibiotic-resistant bacteria
Andersson, J. A., Fitts, E. C., Kirtley, M. L., Ponnusamy, D., Peniche, A. G., Dann, S. M., Motin, V. L., Chauhan, S., Rosenzweig, J. A., Sha, J., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00326-16 · Cited by 53
Liang, L., Huang, M., Xiao, Y., Zen, S., Lao, M., Zou, Y., Shi, M., Yang, X., & Xu, H. (2015) · Inflammation Research · doi:10.1007/s00011-015-0801-5 · Cited by 52
Moroney, J. W., Schlumbrecht, M. P., Helgason, T., Coleman, R. L., Moulder, S., Naing, A., Bodurka, D. C., Jankú, F., Hong, D. S., & Kurzrock, R. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0666 · Cited by 52
Repurposing FDA-approved drugs to combat drug-resistant Acinetobacter baumannii
Chopra, S., Torres-Ortiz, M., Hokama, L. A., Madrid, P. B., Tanga, M. J., Mortelmans, K. E., Kodukula, K., & Galande, A. K. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq353 · Cited by 51
Coelho, E. D., Arrais, J. P., & Oliveira, J. L. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005219 · Cited by 50
High-ThroughputGiardia lambliaViability Assay Using Bioluminescent ATP Content Measurements
Chen, C. Z., Kulakova, L., Southall, N. T., Marugán, J., Galkin, A. G., Austin, C. P., Herzberg, O., & Zheng, W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00618-10 · Cited by 49
Chavali, A. K., Blazier, A. S., Tlaxca, J. L., Jensen, P. A., Pearson, R. D., & Papin, J. A. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-27 · Cited by 48
Drug repurposing a reality: from computers to the clinic
Issa, N. T., Kruger, J., Byers, S. W., & Dakshanamurthy, S. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.12.79 · Cited by 41
Recent Advances in Understanding the Molecular Mechanisms of Tamoxifen Action
Friedman, Z. Y. (1998) · Cancer Investigation · doi:10.3109/07357909809115779 · Cited by 41
A High-Throughput Screening Assay for Small Molecules That Disrupt Yeast Cell Integrity
Krysan, D. J., & DiDone, L. (2008) · SLAS DISCOVERY · doi:10.1177/1087057108320713 · Cited by 40
Wiseman, H., Cannon, M., Arnstein, H. R. V., & Halliwell, B. B. (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(93)90021-r · Cited by 38
Preliminary studies on the palatability of grasses, legumes and herbs to horses
ARCHER, M. (1971) · Veterinary Record · doi:10.1136/vr.89.9.236 · Cited by 36
Villanueva-Lozano, H., Treviño-Rangel, R. D. J., González, G. M., Hernández-Rodríguez, P. A., Camacho-Ortiz, A., Castillo-Reyna, L., Galindo-Alvarado, S. G., & Martínez-Reséndez, M. F. (2018) · Infection · doi:10.1007/s15010-017-1059-3 · Cited by 35
Drug repurposing: mining protozoan proteomes for targets of known bioactive compounds
Sateriale, A., Bessoff, K. E., Sarkar, I. N., & Huston, C. D. (2013) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-001700 · Cited by 32
Wiseman, H., Cannon, M., & Arnstein, H. R. V. (1989) · Biochemical Society Transactions · doi:10.1042/bst0171038 · Cited by 32
den Driessche, F. V., Brackman, G., Swimberghe, R. C. D., Rigole, P., & Coenye, T. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.11.023 · Cited by 31
AN INTEGRATIVE PIPELINE FOR MULTI-MODAL DISCOVERY OF DISEASE RELATIONSHIPS
Glicksberg, B. S., Li, L., Cheng, W., Shameer, K., Hakenberg, J., Castellanos, R., Ma, M., Shi, L., Shah, H., Dudley, J. T., et al. (2014) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814644730_0039 · Cited by 27
Hospital transmittedCandida aurisinfections confirmed in the US
McCarthy, M. (2016) · BMJ · doi:10.1136/bmj.i5978 · Cited by 26
EFFECT OF PENTAMIDINE ON THE GROWTH OF ESCHERICHIA COLI
Amos, H., & Vollmayer, E. (1957) · Journal of Bacteriology · doi:10.1128/jb.73.2.172-177.1957 · Cited by 24
Colquhoun, J. M., Wozniak, R. A. F., & Dunman, P. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143033 · Cited by 22
Anti-Candida activity of the anti-cancer drug tamoxifen.
Beggs, W. H. (1993) · PubMed · Cited by 20
Antistaphylococcal activity of pentamidine
Libman, M., Miller, M. A., & Richards, G. K. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.9.1795 · Cited by 13
Tamoxifen Pharmacovigilance: Implications for Safe Use in the Future
Antimisiaris, D. E., Bae, K.-H. G., Morton, L. J., & Gully, Z. (2017) · The Consultant Pharmacist · doi:10.4140/tcp.n.2017.535 · Cited by 2
Farha, M., Leung, A., Sewell, E., D'Elia, M., Allison, S., Ejim, L., Pereira, P., Pinho, M., Wright, G., & Brown, E. (2013) · UCL Discovery (University College London) · Cited by 2
Self-citation
Cited by
Drug repositioning: Progress and challenges in drug discovery for various diseases
Hua, Y., Dai, X., Xu, Y., Xing, G., Liu, H., Lu, T., Chen, Y., & Zhang, Y. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114239 · Cited by 232
“coli, providing a physical basis for this synergy [144].”
Borrelli, L., Varriale, L., Dipineto, L., Pace, A., Menna, L. F., & Fioretti, A. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.620798 · Cited by 175
New antifungal strategies: Drug combination and co-delivery
Zhu, P., Li, Y., Guo, T., Liu, S., Tancer, R. J., Hu, C., Zhao, C., Xue, C., & Liao, G. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114874 · Cited by 63
Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications
Caldara, M., & Marmiroli, N. (2021) · Pharmaceuticals · doi:10.3390/ph14090915 · Cited by 54
Nour, E. M., El-Habashy, S. E., Shehat, M. G., Essawy, M. M., El-Moslemany, R. M., & Khalafallah, N. M. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01353-4 · Cited by 41
Metadata
- Authors
- Farha, M. A., & Brown, E. D.
- Venue
- Nature Microbiology
- Published
- 2019-03-04
- Volume
- 4
- Issue
- 4
- Pages
- 565-577
- ISSN
- 2058-5276 (ISSN-L)
- OpenAlex
- W2920302906
- Cited by
- 360
- References
- 160
- FWCI
- 26.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.